EMvision Medical Devices Ltd
ASX:EMV
EMvision Medical Devices Ltd
ASX:EMV
Price:
1.9 AUD
-2.56%
Market Closed
Updated:
May 17, 2024
EMvision Medical Devices Ltd
Cash from Financing Activities
|
EMvision Medical Devices Ltd
Cash from Financing Activities Peer Comparison
Comparables:
NTI
IPD
C
CYC
COH
OIL
Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
EMvision Medical Devices Ltd
ASX:EMV
|
Cash from Financing Activities
AU$2.5m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
8%
|
CAGR 10-Years
N/A
|
|
|
Neurotech International Ltd
ASX:NTI
|
Cash from Financing Activities
AU$9.4m
|
CAGR 3-Years
47%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
ImpediMed Ltd
ASX:IPD
|
Cash from Financing Activities
AU$28m
|
CAGR 3-Years
3%
|
CAGR 5-Years
192%
|
CAGR 10-Years
N/A
|
|
C
|
Cyclopharm Ltd
ASX:CYC
|
Cash from Financing Activities
-AU$1m
|
CAGR 3-Years
-1%
|
CAGR 5-Years
-24%
|
CAGR 10-Years
2%
|
|
|
Cochlear Ltd
ASX:COH
|
Cash from Financing Activities
-AU$377.1m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
-9%
|
CAGR 10-Years
-21%
|
|
|
Optiscan Imaging Ltd
ASX:OIL
|
Cash from Financing Activities
AU$16.2m
|
CAGR 3-Years
21%
|
CAGR 5-Years
140%
|
CAGR 10-Years
54%
|
See Also
What is EMvision Medical Devices Ltd's Cash from Financing Activities?
Cash from Financing Activities
2.5m
AUD
2.5m
AUD
Based on the financial report for Jun 30, 2023, EMvision Medical Devices Ltd's Cash from Financing Activities amounts to 2.5m AUD.
What is EMvision Medical Devices Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 5Y
8%
8%
Over the last year, the Cash from Financing Activities growth was 133%. The average annual Cash from Financing Activities growth rates for EMvision Medical Devices Ltd have been -16% over the past three years , 8% over the past five years .
You don't have any saved screeners yet
